Analysis

Important takeaways from Signet Jewelers’ (SIG) Q4 2025 report

Signet Jewelers' (NYSE: SIG) stock rallied in premarket trading on Wednesday after the diamond retailer announced positive financial guidance, despite reporting a

General Mills (GIS) anticipates macroeconomic headwinds to continue through next quarter

Shares of General Mills, Inc. (NYSE: GIS) were down over 2% on Wednesday after the company delivered mixed results for the third

Paychex (PAYX) gears up for Q3 earnings with focus on business expansion

Paychex Inc. (NASDAQ: PAYX), a leading provider of human resources and payroll services, is expanding its artificial intelligence capabilities to stay relevant

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

Signet Jewelers (SIG) Q4 2025 Earnings fall on lower sales

Signet Jewelers Limited (NYSE: SIG) on Wednesday reported a decrease in adjusted earnings and net sales for the fourth quarter of 2025. Fourth-quarter sales declined 6% to $2.35 billion from

March 19, 2025

Paychex (PAYX) gears up for Q3 earnings with focus on business expansion

Paychex Inc. (NASDAQ: PAYX), a leading provider of human resources and payroll services, is expanding its artificial intelligence capabilities to stay relevant in the evolving HR landscape, while also increasing

March 18, 2025

What to look for when KB Home (KBH) reports Q1 2025 earnings results

Shares of KB Home (NYSE: KBH) dropped 1% on Tuesday. The stock has dropped 14% over the past three months. The homebuilder is slated to report its first quarter 2025

March 18, 2025

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top